Ultragenyx Pharmaceutical Inc. (RARE) — Analysis Summary

Ultragenyx Pharmaceutical Inc. (RARE) has a market cap of $2.44B with year-over-year revenue growth of +20.1%. Net margin stands at -85.4%. The stock trades at a P/E ratio of -4.2.

Key Takeaways

• Revenue changed +20.1% year-over-year
• Net margin of -85.4%
• P/E ratio of -4.2

Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, RARE posted revenue growth of +20.1% and trades at a P/E of -4.2.